Can increase sexual desire by activating brain pathways involved in desire and arousal.
Medication type
From $73.33/mo$91.67/mo
Billed quarterly with a three-month commitment paid up front.
“In clinical trials, bremelanotide delivered 2.5–3x greater improvement in sexual desire scores across 1,200+ women.”
Why Bremelanotide
In two trials of over 1,200 premenopausal women with low sexual desire, bremelanotide increased desire scores by 0.5 points versus 0.2 with placebo (p < 0.001), with benefits appearing within the first few weeks and maintained over 6 months.
Source: Kingsberg et al., "Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials," Obstetrics & Gynecology (2019) — the RECONNECT Trials
Bremelanotide also reduced emotional distress about low desire by 0.33 points more than placebo (p < 0.001), with women reporting increased feelings of desire, physical arousal, and improvements in relationship quality.
Source: Kingsberg et al., "Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials," Obstetrics & Gynecology (2019) — the RECONNECT Trials
80% of eligible women opted to continue treatment and maintained improvements in desire and distress through 18 months.
Source: Simon et al., "Long-Term Safety and Efficacy of Bremelanotide for HSDD," Obstetrics & Gynecology (2019) & Davis, "Sexual Dysfunction in Women," NEJM (2024)
BREMELANOTIDE MECHANISM OF ACTION
Bremelanotide activates melanocortin receptors in the brain. These receptors are part of the neural pathway that regulates sexual desire. Unlike treatments that act on blood flow or hormones, bremelanotide works upstream at the source of desire itself.
Step 1
Bremelanotide activates melanocortin receptors in the brain, particularly the MC4R subtype, which is found in areas of the brain believed to be involved in sexual function.
Step 2
This receptor activation is thought to stimulate the release of dopamine — a brain chemical associated with arousal and motivation
Step 3
In clinical trials, women using bremelanotide reported increased feelings of sexual desire and reduced distress related to low desire.
ABOUT AROUSAL PEPTIDE
Formulated with bremelanotide to support libido
From $151.20/mo$210.00/mo
Billed quarterly with a three-month commitment paid up front.
Better sex support with apomorphine, tadalafil, and vardenafil
From $47.73/mo$70.00/mo
Billed quarterly with a three-month commitment paid up front.
FDA-approved for type 2 diabetes
From $25.00/mo$40.00/mo
Billed quarterly with a three-month commitment paid up front.
FDA-approved for menopausal symptoms
From $26.00/mo
Billed quarterly with a three-month commitment paid up front.
FDA-approved for type 2 diabetes
From $20.00/mo$35.00/mo
Billed quarterly with a three-month commitment paid up front.
May support hair growth
From $13.33/mo$30.00/mo
Billed quarterly with a three-month commitment paid up front.
FDA-approved for ED
From $24.00/mo$40.00/mo
Billed quarterly with a three-month commitment paid up front.
FDA-approved to treat photoaging
From $25.00/mo$45.00/mo
Billed quarterly with a three-month commitment paid up front.
Answer a few quick questions and we'll match you with the best option for your goals. A physician reviews every recommendation, and there is no charge until your prescription is approved.
Get a RecommendationCompounded medications are not FDA-approved, and the FDA does not evaluate them for safety, effectiveness, or quality prior to use. This page is intended for educational purposes only and is not intended to provide medical advice, diagnosis or treatment. Medication eligibility and prescriptions are determined solely by licensed medical providers based on clinical appropriateness. Not all individuals will qualify for medication-based treatment.
Can increase sexual desire by activating brain pathways involved in desire and arousal.
Medication type
From $73.33/mo$91.67/mo
Billed quarterly with a three-month commitment paid up front.
“In clinical trials, bremelanotide delivered 2.5–3x greater improvement in sexual desire scores across 1,200+ women.”
Why Bremelanotide
In two trials of over 1,200 premenopausal women with low sexual desire, bremelanotide increased desire scores by 0.5 points versus 0.2 with placebo (p < 0.001), with benefits appearing within the first few weeks and maintained over 6 months.
Source: Kingsberg et al., "Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials," Obstetrics & Gynecology (2019) — the RECONNECT Trials
Bremelanotide also reduced emotional distress about low desire by 0.33 points more than placebo (p < 0.001), with women reporting increased feelings of desire, physical arousal, and improvements in relationship quality.
Source: Kingsberg et al., "Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials," Obstetrics & Gynecology (2019) — the RECONNECT Trials
80% of eligible women opted to continue treatment and maintained improvements in desire and distress through 18 months.
Source: Simon et al., "Long-Term Safety and Efficacy of Bremelanotide for HSDD," Obstetrics & Gynecology (2019) & Davis, "Sexual Dysfunction in Women," NEJM (2024)
BREMELANOTIDE MECHANISM OF ACTION
Bremelanotide activates melanocortin receptors in the brain. These receptors are part of the neural pathway that regulates sexual desire. Unlike treatments that act on blood flow or hormones, bremelanotide works upstream at the source of desire itself.
Step 1
Bremelanotide activates melanocortin receptors in the brain, particularly the MC4R subtype, which is found in areas of the brain believed to be involved in sexual function.
Step 2
This receptor activation is thought to stimulate the release of dopamine — a brain chemical associated with arousal and motivation
Step 3
In clinical trials, women using bremelanotide reported increased feelings of sexual desire and reduced distress related to low desire.
ABOUT AROUSAL PEPTIDE
Formulated with bremelanotide to support libido
From $151.20/mo$210.00/mo
Billed quarterly with a three-month commitment paid up front.
Better sex support with apomorphine, tadalafil, and vardenafil
From $47.73/mo$70.00/mo
Billed quarterly with a three-month commitment paid up front.
FDA-approved for type 2 diabetes
From $25.00/mo$40.00/mo
Billed quarterly with a three-month commitment paid up front.
FDA-approved for menopausal symptoms
From $26.00/mo
Billed quarterly with a three-month commitment paid up front.
FDA-approved for type 2 diabetes
From $20.00/mo$35.00/mo
Billed quarterly with a three-month commitment paid up front.
May support hair growth
From $13.33/mo$30.00/mo
Billed quarterly with a three-month commitment paid up front.
FDA-approved for ED
From $24.00/mo$40.00/mo
Billed quarterly with a three-month commitment paid up front.
FDA-approved to treat photoaging
From $25.00/mo$45.00/mo
Billed quarterly with a three-month commitment paid up front.
Answer a few quick questions and we'll match you with the best option for your goals. A physician reviews every recommendation, and there is no charge until your prescription is approved.
Get a RecommendationCompounded medications are not FDA-approved, and the FDA does not evaluate them for safety, effectiveness, or quality prior to use. This page is intended for educational purposes only and is not intended to provide medical advice, diagnosis or treatment. Medication eligibility and prescriptions are determined solely by licensed medical providers based on clinical appropriateness. Not all individuals will qualify for medication-based treatment.